GlaxoSmithKline
GSK
#260
Rank
NZ$124.09 B
Marketcap
$60.83
Share price
-1.01%
Change (1 day)
4.06%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.67

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.87. In 2022 the company made an earnings per share (EPS) of $14.21 an increase over its 2021 EPS that were of $5.02.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.67-60.09%
2022$14.21183.39%
2021$5.02-17.83%
2020$6.1021.82%
2019$5.0123.91%
2018$4.04141.48%
2017$1.6764.6%
2016$1.02-90.64%
2015$10.87178.14%
2014$3.91-48.16%
2013$7.5422.63%
2012$6.15-11.32%
2011$6.93230.25%
2010$2.10-70.98%
2009$7.236.76%
2008$6.78-15.14%
2007$7.987.82%
2006$7.4019.61%
2005$6.1918.56%
2004$5.220.36%
2003$5.2050.39%
2002$3.4631.13%
2001$2.64-25.43%
2000$3.5431.58%
1999$2.691.05%
1998$2.66-0.98%
1997$2.69-10.07%
1996$2.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.33-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.12-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.05-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.27 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.33-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.35-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.46-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA